The development of effective treatments for Central Nervous System (CNS) disorders often relies on sophisticated chemical synthesis, requiring highly specific and pure intermediates. N,N-Dipropyl-2-methyl-3-nitrophenylethanamine, identified by its CAS number 91374-23-1, is a pivotal compound in this arena, primarily known for its use as an intermediate in the synthesis of dopamine receptor agonists. These agonists are crucial for managing conditions such as Parkinson's disease.

For researchers and pharmaceutical companies, sourcing this vital pharmaceutical intermediate efficiently is paramount. When you choose to buy N,N-Dipropyl-2-methyl-3-nitrophenylethanamine, prioritizing a manufacturer with a strong track record in producing high-purity chemicals (e.g., ≥99%) is essential. A reliable supplier based in China can offer competitive advantages, including cost-effectiveness and substantial production capacity.

The significance of N,N-Dipropyl-2-methyl-3-nitrophenylethanamine lies in its ability to be transformed into active pharmaceutical ingredients (APIs) that modulate neurotransmitter activity. Its role as a precursor for Ropinirole highlights its importance in creating medications that improve the quality of life for patients with neurological conditions. Therefore, understanding the technical specifications and ensuring consistent quality from your chemical synthesis intermediate supplier is critical.

Inquiries regarding the price of N,N-Dipropyl-2-methyl-3-nitrophenylethanamine are common, as procurement teams aim to optimize their budgets without compromising on quality. Working directly with manufacturers or their authorized distributors can provide the best value and ensure the integrity of the supply chain. The advantages of partnering with a Chinese manufacturer often include competitive lead times and the ability to scale production according to demand.

In summary, N,N-Dipropyl-2-methyl-3-nitrophenylethanamine is an indispensable intermediate for the pharmaceutical industry, particularly in the development of CNS therapies. By engaging with reputable Chinese manufacturers and suppliers, organizations can secure a high-quality supply of this critical compound, driving innovation and patient care forward.